A wound is a disruption of the normal structure and function of the skin and soft tissue architecture. An acute wound demonstrates normal physiology and healing is anticipated to progress through the expected stages of wound healing, whereas a chronic wound is broadly defined as one that is physiologically impaired. Wound care provide proper healing that focuses on injury and damage to skin and its underlying structure. Wound dressings help to eliminate dead space, control exudate, prevent bacterial overgrowth by ensuring proper fluid balance, cost-efficiency, and are manageable for the patient and nursing staff. Global wound care market has witnessed various technological advancements and emerged as a standard solution to treat acute and chronic wounds. Conventional measures of wound care management are being rapidly replaced with advanced wound measure products due to the effectiveness of the latter for managing wounds, which enables faster healing.
The global wound care market is estimated to be valued at US$ 21,218.5 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030).
Figure 1. Global Wound Care Market Share (%), by Wound Type, 2022
Global Wound Care Market - Drivers
Increasing number of product approval by regulatory authorities such as the U.S. Food and Drug Administration is expected to drive the global wound care market. For instance, in September 2021, Omeza, a healthcare company, announced that they had received an approval from the U.S. Food and Drug Administration for Omeza collagen matrix, a wound care matrix comprised of hydrolyzed fish collagen for the management of chronic wound care including partial and full-thickness wounds, diabetic ulcers, chronic vascular ulcers, surgical wounds and draining wounds.
|Base Year:||2021||Market Size in 2022:||US$ 21,218.5 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||5.3%||2030 Value Projection:||US$ 32,127.5 Mn|
3M, Baxter, Coloplast A/S, Acelity L.P. Inc., Integra LifeSciences, Johnson & Johnson Services, Inc., Axio Biosolutions Pvt Ltd., Omeza, Smith & Nephew Plc., Cardinal Health, Schulke & Mayr GmbH, Bactiguard AB, Wound Care Advantage, LLC, Noventure, EO2 Concepts, Essity, Hydrofera, Advance Medical, Inc., CutisCare, Convatec Group PLC, and Organogenesis Inc.
|Restraints & Challenges:||
Figure 2. Global Wound Care Market Value (US$ Million), by Region, 2022
Global Wound Care Market – Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a negative impact on the global wound care market. For instance, in September 2021, according to the data published in the American Journal of Managed Care, chronic wound care had been delayed during COVID-19 pandemic, which results in several infections, increased hospitals admission. Therefore, it will be critical for providers, hospitals, outpatient departments to understand and plan for a surge in patients with untreated and unmanaged non-healing wounds and related acute-on-chronic complications as a result of delayed care during the COVID-19 pandemic. Moreover, some patients have avoided the appointments for wound care clinics due to fear of exposure to COVID-19.
Global Wound Care Market: Key Developments
Adoption of inorganic strategies such as product launch by the key market players is expected to drive the global wound care market over the forecast period. For instance, in March 2022, Cardinal Health, a health care company, announced that they had launched surgical incise drape, which helps reduce the risk of surgical site contamination with organisms typically associated with surgical site infections (SSIs) and also, improve patient care by reducing the risk of microbial contamination.
Global Wound Care Market: Restraint
Increasing number of product recalls by regulatory authorities such as U.S. Food and Drug Administration, is the major factor that is expected to hinder growth of the global wound care market. For instance, in November 2019, U.S. Food and Drug Administration recalled Class 2 device 3M Durapore advanced surgical tape, which was manufactured by 3M, a healthcare company, because a long term exposure of advanced surgical tape lead to continuous high moisture clinical applications which may cause tape bond failure.
Global Wound Care Market - Key Players
Major players operating in the global wound care market include 3M, Baxter, Coloplast A/S, Acelity L.P. Inc., Integra LifeSciences, Johnson & Johnson Services, Inc., Axio Biosolutions Pvt Ltd., Omeza, Smith & Nephew Plc., Cardinal Health, Schulke & Mayr GmbH, Bactiguard AB, Wound Care Advantage, LLC, Noventure, EO2 Concepts, Essity, Hydrofera, Advance Medical, Inc., CutisCare, Convatec Group PLC, and Organogenesis Inc.
Wound care refers to specific types of treatment for pressure sores, skin ulcers and other wounds that break the skin. Wound healing is a complex process of normal function and structure of skin and underlying soft tissues that is caused by trauma or chronic mechanical stress such as pressure ulcer. Wound management involves a comprehensive care plan with consideration of all factors contributing to and affecting the wound and the patient. The overarching aim of wound care is to provide the optimum conditions in which wound healing can take place or in the case of chronic, non-healing wounds, to facilitate the most advantageous quality of life. The new wound healing technology involves stem cell therapy for faster healing wound. The stem cell therapy for wound healing in still under exploration, however, the approach of regenerative medicine has emerged as an alternative to improve the outcome of healing and has potential in treating wounds more efficiently with skin regeneration technology. Therefore, such novel treatment methods hold immense potential to propel the wound care market growth.
Adoption of inorganic strategies such as agreement by the key market players is expected to drive the global wound care market growth. For instance, in July 2021, Bactiguard AB, a medical technology company, and Schulke & Mayr GmbH, provider of infection prevention solutions, signed an agreement for wound care in Germany. This agreement will complement Schulke & Mayr GmbH’s comprehensive product range of antiseptic and wound care products with Bactiguard’s hypochlorous acid-based portfolio. Hypochlorous acid is an antimicrobial substance that reduces the risk of infection and promotes wound healing.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.